Related Experiment Video
Updated: Mar 3, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?
Mark W Kennedy1,2, Enrico Fabris1,2, Harry Suryapranata1,2
1Isala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Insights
Diabetes mellitus (DM) patients with coronary atherosclerosis may face high cardiac event risk even without ischemia. This review questions if factors beyond ischemia are crucial for risk stratification in these patients.
Area of Science:
- Cardiology
- Diabetology
- Vascular Biology
Background:
- Diabetes mellitus (DM) significantly increases cardiovascular morbidity and mortality, with higher rates of coronary artery disease.
- Atherosclerosis in DM patients progresses faster and is more complex than in non-DM individuals.
- Ischemia is a primary predictor of cardiac events, guiding revascularization strategies.
Purpose of the Study:
- To review evidence for ischemia-driven revascularization in DM patients.
- To challenge the sole reliance on ischemia for cardiovascular risk prediction in DM.
- To explore if factors beyond ischemia, like microvascular disease and plaque characteristics, are vital for risk stratification.
Main Methods:
- Literature review of current evidence on revascularization strategies in DM.
- Analysis of studies investigating cardiovascular outcomes in DM patients with and without ischemia.
- Examination of factors beyond ischemia, including atherosclerosis burden, progression, and plaque composition.
Main Results:
- Recent data suggest DM patients with coronary atherosclerosis may have elevated cardiac event risk, even without detectable ischemia.
- The predictive value of ischemia alone for cardiac events in DM patients is questioned.
- Non-ischemic factors may influence cardiovascular outcomes in DM.
Conclusions:
- Ischemia may not be the only critical factor for predicting cardiovascular outcomes in all DM patients.
- Microvascular disease, atherosclerosis burden, progression, and plaque composition warrant consideration for refined risk stratification.
- A comprehensive approach beyond ischemia is needed for managing cardiovascular risk in DM.
Abstract:
Diabetes mellitus (DM) is associated with an excess in cardiovascular morbidity and mortality, and is characterized by increased rates of coronary artery disease. Furthermore, once atherosclerosis is established, this is associated with an increased extent, complexity and a more rapid progression than seen in non-DM patients. Ischemia is the single most important predictor of future hard cardiac events and ischemia correction remains the cornerstone of current revascularization strategies. However recent data suggests that, in DM patients, coronary atherosclerosis despite the absence of ischemia, detected by either invasive or non-invasive methods, may not be associated with the same low risk of future cardiac events as seen in non-DM patients. This review seeks to examine the current evidence supporting an ischemia driven revascularization strategy, and to challenge the notion that ischemia is the only clinically relevant factor in the prediction of cardiovascular outcomes in all-comer DM patients. Specifically, we examine whether in DM patients certain characteristics beyond ischemia, such as microvascular disease, coronary atherosclerosis burden, progression and plaque composition, may need to be considered for a more refined risk stratification in these high-risk patients.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Angina IV: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes Mellitus: Type 2 and Gestational

